Evidence map›Paper›PMID 37941305›Full record

Trial reportMultiple sclerosis (Houndmills, Basingstoke, England)2023

A low-fat diet improves fatigue in multiple sclerosis: Results from a randomized controlled trial.

Emma Chase, Vicky Chen, Kayla Martin, Michael Lane, Lindsey Wooliscroft, Claire Adams, Jessica Rice, Elizabeth Silbermann, Christopher Hollen, Allison Fryman and 7 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Multiple sclerosis (Houndmills, Basingstoke, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Emma ChaseDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Vicky ChenDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.
Kayla MartinDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.
Michael LaneDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.
Lindsey WooliscroftDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.ORCID 0000-0001-5377-6185
Claire AdamsDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Jessica RiceDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.ORCID 0000-0001-5095-808X
Elizabeth SilbermannDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.
Christopher HollenDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.
Allison FrymanDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.
Jonathan Q PurnellDepartment of Medicine, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Carly VongDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Anna OrbanDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA.
Angela HorganOregon Clinical & Translational Research Institute, Portland, OR, USA.
Akram KhanDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0003-3091-632X
Priya SrikanthSchool of Public Health, Oregon Health & Science University-Portland State University, Portland, OR, USA.
Vijayshree YadavDepartment of Neurology, Oregon Health & Science University, Portland, OR, USA/Department of Neurology, Veterans Affairs Portland Health Care System, Portland, OR, USA.ORCID 0000-0001-8476-403X
Oregon Health & Science University · USOregon Research Institute · USPortland State University · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
OREGON CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024140 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI ORWOLL, ERIC S. · 2006 to 2011
$61.1M
NCATS NIH HHS UL1 TR002369NCRR NIH HHS UL1 RR024140
6 · The paper itself

Abstract

backgroundFatigue can be a disabling multiple sclerosis (MS) symptom with no effective treatment options.

objectiveDetermine whether a low-fat diet improves fatigue in people with MS (PwMS).

methodsWe conducted a 16-week randomized controlled trial (RCT) and allocated PwMS to a low-fat diet (active, total daily fat calories not exceeding 20%) or wait-list (control) group. Subjects underwent 2 weeks of baseline diet data collection (24-hour diet recalls (24HDRs)), followed by randomization. The active group received 2 weeks of nutrition counseling and underwent a 12-week low-fat diet intervention. One set of three 24HDRs at baseline and week 16 were collected. We administered a food frequency questionnaire (FFQ) and Modified Fatigue Impact Scale (MFIS) every 4 weeks. The control group continued their pre-study diet and received diet training during the study completion.

resultsWe recruited 39 PwMS (20-active; 19-control). The active group decreased their daily caloric intake by 11% (95% confidence interval (CI): -18.5%, -3.0%) and the mean MFIS by 4.0 (95% CI: -12.0, 4.0) compared to the control (intent-to-treat). Sensitivity analysis strengthened the association with a mean MFIS difference of -13.9 (95% CI: -20.7, -7.2).

conclusionsWe demonstrated a significant reduction in fatigue with a low-fat dietary intervention in PwMS.

Indexed as

Diet, Fat-RestrictedMultiple SclerosisFatigueHumansMental RecallTreatment Outcomeactigraphyclinical trialfatiguelow-fat dietMultiple sclerosisrandomized controlled trial

Identifiers

PMID37941305
PMCPMC10655900
OpenAlexW4388536597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.